Legend:
"+" m eans combination product, both fixed-dose combination (co-formulated) and co-packaged product (i.e. co-blister)
[A+B] + C means A and B are in a fixed-dose formulation and C is co-packaged
"*" refers to products approved by both WHO Prequalification Programme and US FDA
USFDA1 approved by US FDA; USFDA2 tentatively approved by US FDA